Enveric Biosciences, Inc.
ENVB
$1.33
$0.00920.70%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/14/2025
-
GuruFocus
8/14/2025
-
GuruFocus
8/14/2025
-
SeekingAlpha.com: All News
8/14/2025
-
Business Wire
7/28/2025
-
Market Exclusive
7/23/2025
-
GuruFocus
7/23/2025
-
GuruFocus
7/23/2025
-
GuruFocus
7/23/2025
-
The Fly
7/23/2025
-
Business Wire
7/20/2025
-
Market Exclusive
7/15/2025
-
GuruFocus
7/15/2025
-
GuruFocus
7/15/2025
-
GuruFocus
7/15/2025
-
The Fly
7/15/2025
-
Business Wire
6/24/2025
-
GuruFocus
6/24/2025
-
GuruFocus
6/24/2025
-
GuruFocus
6/24/2025
-
Business Wire
6/16/2025
-
Market Exclusive
6/16/2025
-
GuruFocus
6/16/2025
-
GuruFocus
6/16/2025
-
Business Wire
6/10/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
239-302-1707
Address
4851 Tamiami Trail N
Naples, FL 34103
Naples, FL 34103
Country
Year Founded
--
Business Description
Sector
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers...
more